BioCentury
ARTICLE | Financial News

Xoma raises $45 million

June 26, 2001 7:00 AM UTC

XOMA, which is in Phase III testing of its Xanelim anti-CD11a monoclonal antibody for psoriasis, raised $45 million through the sale of 3 million shares at $15. The deal was underwritten by U.S. Banco...